These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12628950)

  • 1. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
    Vermes E; Ducharme A; Bourassa MG; Lessard M; White M; Tardif JC;
    Circulation; 2003 Mar; 107(9):1291-6. PubMed ID: 12628950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
    Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
    Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.
    Shindler DM; Kostis JB; Yusuf S; Quinones MA; Pitt B; Stewart D; Pinkett T; Ghali JK; Wilson AC
    Am J Cardiol; 1996 May; 77(11):1017-20. PubMed ID: 8644628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
    Jong P; Yusuf S; Rousseau MF; Ahn SA; Bangdiwala SI
    Lancet; 2003 May; 361(9372):1843-8. PubMed ID: 12788569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
    Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
    Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB; Yusuf S; Naylor CD
    Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
    Exner DV; Dries DL; Domanski MJ; Cohn JN
    N Engl J Med; 2001 May; 344(18):1351-7. PubMed ID: 11333991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
    de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
    Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators.
    Kostis JB; Shelton B; Gosselin G; Goulet C; Hood WB; Kohn RM; Kubo SH; Schron E; Weiss MB; Willis PW; Young JB; Probstfield J
    Am Heart J; 1996 Feb; 131(2):350-5. PubMed ID: 8579032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
    Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
    Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction.
    Kostis JB
    Am J Hypertens; 1995 Sep; 8(9):909-14. PubMed ID: 8541006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
    Dries DL; Exner DV; Gersh BJ; Domanski MJ; Waclawiw MA; Stevenson LW
    J Am Coll Cardiol; 1998 Sep; 32(3):695-703. PubMed ID: 9741514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
    Anker SD; Negassa A; Coats AJ; Afzal R; Poole-Wilson PA; Cohn JN; Yusuf S
    Lancet; 2003 Mar; 361(9363):1077-83. PubMed ID: 12672310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.